Publications by authors named "Deborah Finco"

Claim this Profile
N
Neutralizing Antibody Validation Testing and Reporting Harmonization.
Heather Myler, João Pedras-Vasconcelos, Todd Lester, Francesca Civoli, Weifeng Xu, Deborah Finco

AAPS J· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Immunogenicity Risk Assessment Strategy for a Low Risk Monoclonal Antibody.
Robert Kernstock, Gizette Sperinde, Deborah Finco, Roslyn Davis, Diana Montgomery

AAPS J· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioanalytical assays in support of tanezumab developmental and reproductive toxicity studies: challenges and learnings.
Susan Hurst, Tracey Clark, Deborah Finco, Amanda Leskovar, Debra O'Neil

Bioanalysis· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokine release: A workshop proceedings on the state-of-the-science, current challenges and future directions.
Christine Grimaldi, Deborah Finco, Madeline M Fort, Daniel Gliddon, Kirsty Harper

Cytokine· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity/hypersensitivity of biologics.
Michael W Leach, James B Rottman, M Benjamin Hock, Deborah Finco, Jennifer L Rojko

Toxicol Pathol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for the validation of cell-based assays used for the detection of neutralizing antibody immune responses elicited against biological therapeutics.
Shalini Gupta, Viswanath Devanarayan, Deborah Finco, George R Gunn, Susan Kirshner

J Pharm Biomed Anal· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multiple-dose toxicity study of tanezumab in cynomolgus monkeys.
Mark Zorbas, Susan Hurst, David Shelton, Mark Evans, Deborah Finco

Regul Toxicol Pharmacol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of competitive ligand-binding assay and bioassay formats for the measurement of neutralizing antibodies to protein therapeutics.
Deborah Finco, Daniel Baltrukonis, Adrienne Clements-Egan, Kathy Delaria, George R Gunn

J Pharm Biomed Anal· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Embryo-fetal developmental toxicity of figitumumab, an anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody, in cynomolgus monkeys.
Christopher J Bowman, Gary Chmielewski, Satoru Oneda, Deborah Finco, Mary A Boucher

Birth Defects Res B Dev Reprod Toxicol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis